comparemela.com

Williama Linton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Single-Dose Psilocybin Treatment for Major Depressive Disorder

This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with majo

United statesWilliama lintonBlake mycoskieCraig nerenbergAlexandra cohenClexio biosciencesMatt mullenwegNeurocrine biosciencesDenovo biopharmaBristol myers squibbTim ferrissSage pharmaceuticalsPromega corporationUsona instituteUsona institute incNoven pharmaceuticals

Psilocybin Reduces Symptoms, Disability in Major Depression

Phase 2 data suggest significant sustained benefits with an experimental psilocybin drug in the treatment of major depressive disorder.

United statesNew yorkCaleb alexanderWilliama lintonRachel yehudaAmy lehrnerDrug administrationFournier family foundationMultidisciplinary association for psychedelic studies public benefitJournal of the american medical associationJohns hopkins university in baltimoreTurnbull family foundationUsona instituteAlexandra cohen foundationIcahn school of medicine at mount sinaiTiny blue dot foundation

vimarsana © 2020. All Rights Reserved.